Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Population Science
Association Between Changes in Serum N-Terminal Pro B-Type Natriuretic Peptide Levels and All-Cause and Cause-Specific Mortality ― The Hisayama Study ―
Asahi Kato, Emi Oishi , Akihiro Maezono, Satoko Sakata, Yoshihiko Furuta, Mao Shibata, Jun Hata, Tetsuro Ago, Kohtaro Abe, Toshiharu Ninomiya
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML
Supplementary material

2026 Volume 90 Issue 10 Pages 1368-1377

Details
Abstract

Background: Few epidemiological studies have investigated the association between changes in serum N-terminal pro B-type natriuretic peptide (NT-proBNP) and mortality in the general Asian population.

Methods and Results: We followed 2,703 community-dwelling Japanese residents aged ≥40 years who had serum NT-proBNP concentrations measured in both 2002–2003 and 2007–2008 over a median period of 10.3 years. Changes in NT-proBNP were categorized as decreasing (change ≤−25%), no change (−25%<change<+25%), or increasing (change ≥+25%). Mortality hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. During the follow-up period, 497 deaths occurred (108 cardiovascular, 389 non-cardiovascular). Compared with the no-change group, multivariable-adjusted HRs in the increasing group were 1.73 (95% CI 1.37–2.17), 1.76 (95% CI 1.08–2.87), and 1.71 (95% CI 1.32–2.22) for all-cause, cardiovascular, and non-cardiovascular mortality, respectively. Subgroup analyses by baseline serum NT-proBNP concentration (2002–2003) showed consistent associations with all-cause mortality in both lower (<125 pg/mL) and higher (≥125 pg/mL) NT-proBNP groups, with a tendency towards stronger associations in the higher NT-proBNP group.

Conclusions: Changes in serum NT-proBNP concentrations may indicate mortality risk in a community-dwelling Asian population.

Fullsize Image
Content from these authors
© 2026, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top